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ABSTRACT 
It is well known that peptide and protein fibrillation is strongly affected by the 
solution conditions, but a fundamental understanding of how amyloid fibril nucleation 
depends on solution pH, salt concentration and solvent is absent. Here we use 
expressions from Debye-Hckel theory to describe the interactions between charged 
amino-acids in combination with our recently developed non-standard nucleation 
theory to predict the concentration dependence of the fibril nucleation rate under 
different solvent conditions. The general rule that emerges from these considerations 
is that changes in solution pH, salt concentration and solvent that increase the bonding 
energy between the fibril building blocks decrease the fibril solubility and promote 
fibril nucleation, in line with experimental observations. The simple analytical 
relations between the nucleation rate, the fibrils solubility and the binding energies 
provide a tool to control and understand amyloid fibril formation by changing the 
solution conditions.  
 
 
 
 
INTRODUCTION 
Proteins when dissolved in aqueous solution that contain salt form a polyelectrolyte 
solution. Because amino acids contain ionisable groups, the predominant ionic form 
of these molecules in solution depends on the pH. The interactions between the amino 
acids of the proteins depend on their partial charges, but also on the concentrations of 
the ions in solution, which shield the interactions between charged amino acids, and 
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the solvent, as a change in the dielectric constant will affect the electrostatic screening 
between charged residues. Understanding the effects of solution pH, salt and solvent 
on the solubility and nucleation rate of amyloid fibrils is important e.g. for biomedical 
applications because proteins need to function under physiological conditions 
1
.  
Solution conditions can strongly affect the kinetics and mechanism of amyloid 
fibril formation as well as their morphology. A prominent example is the aggregation 
of amyloid β peptide related to AlzheimerÕs disease for which there is an optimum pH 
range for fibril formation and the fibril morphology is strongly pH dependent (see, 
e.g. Ref. 
2-5
). A strong pH dependence has been reported for numerous other proteins 
including β2-microglobulin 
6
, gelsolin 
7
, HypF N-terminal domain 
8
, transthyretin 
9
, 
α-synuclein 
10
, prion protein 
10
, SH3 domain 
11
, major cold-shock protein 
12
 and the 
ABri peptide 
13
. For example in the case of α-synuclein it has been shown 
10
 that the 
aggregation lag time increases with solution pH and decreases with the addition of 
salt, and its fibrillation rate can be changed by orders of magnitude when the pH is 
changed by only a few tenths of a unit 
14
.  
To obtain a quantitative understanding of how the interactions between the 
proteins depend on the solvent conditions and their assembly behavior is challenging. 
The (overall) charge of the protein seems to be a central parameter. For example the 
removal of a single charged amino acid can shift the pH dependence by a full unit 
15
, 
and the concentration above which monomeric peptides aggregate correlates with its 
overall charge 
16
. More generally it has been shown 
17
 that the pH at maximal fibril 
formation correlates with the pH dependence of the protein solubility (but not 
stability) and is near the isoelectric point, where the protein is expected to be least 
soluble. The important role of charge has been used to design peptides in which  
pH can be used 
18,19
 as a reversible switch for the formation of hydrogels.  
 Theoretical approaches to provide insight into solvent effects on amyloid 
fibrillation include models that use physiochemical properties of the protein to predict 
their aggregation propensities 
20-23
, and rate equations to analyze protein fibrillation 
experiments 
24,25
, but they differ to our approach in that they do not provide 
information about the fibril solubility and the nucleation rate. Molecular simulations 
using a full atomistic description of proteins have been used to investigate protein 
aggregation (see e.g. recent review by Morriss-Andrews and Shea 
26
), but they are 
restricted to simulations of self-assembly of a few peptide fragments and short times. 
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Using simplified models it has been possible to perform larger scale simulations, but 
studying solvent effects on protein aggregation is notoriously difficult 
26
. 
 The objective of this work is to apply our newly developed nucleation model 
27-29
, in combination with Debye-Hckel theory to describe the interactions between 
charged amino acids, to predict how the solvent affects the fibril solubility, the 
threshold concentration below which fibril formation becomes biologically irrelevant, 
and the nucleation rate. In particular, our considerations pertain to changes in (i) the 
solution pH, (ii) salt concentration, and (iii) the solvent. As in our previous work 
29
, 
the emphasis of this work is to reveal the general principles that underlie the fibril 
nucleation and for this reason we apply our theoretical framework to a model peptide 
system rather than a specific protein.  
 
METHOD 
 
Fraction of ionised groups. Every peptide has two titratable groups at the N- 
and C-terminal residues and the side chain groups when they are composed of one (or 
several) of the following seven amino acids: histidine, lysine, arginine, aspartate, 
glutamate, cysteine, and tyrosine. During titration with a strong base, the titratable 
groups of a peptide lose their protons in a stepwise manner. At low pH the 
carboxylate group is uncharged whereas the ammonium group is protonated and has a 
charge +1. When base is added, the carboxyl group loses its proton to become a 
negatively charged carboxylate group around pH≈ 2.3 . As more base is added, the 
side chain groups of the titratable amino acids lose their proton at their characteristic 
pKa values, and adding additional base results in the ammonium ion losing its proton 
to become a uncharged carboxylate group at pH≈ 9.7 . Although the titration and pKa 
values of all individual amino acids are known and tabulated, the pKa values of these 
amino acids differ from those of free amino acids because they are affected by their 
microenvironment. The pH-dependence of the fraction of ionised groups can be 
calculated by using the Henderson-Hasselbach equation and is given by 
f =
1
1+10
 pH±pKa
       (1) 
where the exponent Ð pH + pKa is used  if the titratable group becomes charged  with 
increasing pH, whereas + pH Ð pKa when it becomes charged with decreasing pH.  
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Debye-Hckel theory. Our consideration of the electrostatic interactions 
between charged amino acids is based on Debye-Hckel theory, within the 
dimensionless potential of an amino acid at distance r is given by  
eV (r) / kT = ∓
λB
r
exp −r / λD( ) f      (2) 
Here e is the elementary charge, k the Boltzmann factor, T the temperature, V the 
dimension-bearing potential, and f   is the fractional charge of the titratable group as 
given in Eq. (1) above. The Bjerrum length λ
B
= e
2
/ 4πε
0
ε
r
kT is the length at which 
the electrostatic interaction between two elementary charges is comparable to the 
thermal energy kT and ε
0
 is the permittivity in vacuum. For water with a dielectric 
constant ε
r
= 80  and at T = 300 K it is given by λ
B
= 0.7  nm. The Debye length 
λ
D
= ε
0
ε
r
kT / e
2
c
i
z
i
i
∑  is a measure for the electrostatic screening in the solution 
where the concentrations c
i
 of salt ions of type i in solution is in units of mol/l (or 
mol/m
3
). In a 1:1 electrolyte where the charge of all ions is z
i
=1 , the expression 
simplifies to λ
D
= ε
0
ε
r
kT / e
2
N
A
2C  where N
A
 is AvogadroÕs number and the salt 
concentration C is in moles per m
3
. For example λ
D
 for 1 mol/m
3
 (1 mM) and 100 
mol/m
3
 (100 mM) salts in water are 10 nm and 1 nm, respectively. This corresponds 
to an ionic strength I of 1mM and 100 mM, respectively, typically used in 
experiments on protein aggregation. 
 
 The effect of solvent on pKa value. The dissociation constant of a standard 
dissociation reaction HA →←  H
+
+A
−
 is given by K
a
=
H
+!" #$ A
−!" #$
HA[ ]
=
A
−!" #$
2
HA[ ]
, where we 
have used that the concentration of cations, H
+!" #$ , and anions, A
−"# $% , in a 1:1 
electrolyte are equal. On the simplest level the effect of solvent on the pKa value may 
be considered by the difference in coulomb energy, Δu ≈ e
2
/ 4πε
0
ε
r
a+ + a−( )kT( )  , on 
separating two monovalent ions from contact in a solvent with dielectric constant εr, 
where a+ and a- are the radii of the cation and anion, respectively. The concentration 
of dissociated ions in solution is then given by
30
, 
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X
S
≈ exp(−Δu / kT ) = exp −
e
2
4πε0εr a+ + a−( )kT
$
%
&
&
'
(
)
)
 and the value of this dimensionless 
parameter may be identified as the solubility of the monovalent ions in any solvent, in 
mole-fraction units. As the dissociation constant Ka is proportional to Xs, it follows 
that K
a
 is proportional to e−const/εr , or  
 
pK
a
= − log10 Ka ∝− log10 Xs ∝1/εr .     (3)  
This relation predicts that the pKa values in non-polar solvents are higher than in 
water. While the derived relation is far to simple to quantitatively account for the pKa 
dependence for amino acids in different solvents, it has been shown to predict trends 
for monovalent salts and amino acids reasonably well (see e.g. Fig. 3.3 of Ref. 
30
).  
 
Fibril model. In our model system 27,28,31 we assume that each peptide is 
composed of 10 amino acids. In the fibril the peptide is in an extended β-strand 
conformation and each amino acid can form bonds with nearest neighbour amino 
acids only (Fig.1). We denote ε the binding energy of amino acids between two-
nearest neighbour β-strands in a β-sheet that form hydrogen bonds, εh is the binding 
energy of amino acids that form hydrophobicity mediated bonds, and εc is the binding 
energy due to columbic bonds between neighbour β-strands. The dimensionless 
specific surface energy of the 1β-sheet face perpendicular to the β-sheet lengthening 
axis can then be written as 
ψ = nα + n
h
α
h
− n
c
α
c
       (4) 
where α = ε / 2kT , α
h
= ε
h
/ 2kT  and α
c
= ε
c
/ 2kT  are the dimensionless specific 
surface energies per amino acid at the 1β-sheet ends due to hydrogen, hydrophobic 
and columbic bonds, respectively. The nÕs are the corresponding numbers of such 
bonds of the amino acids at the 1β-sheet ends. While hydrogen and hydrophobicity 
mediated bonds are attractive, columbic bonds are repulsive, which is taken into 
account by the minus sign in eq. 4. Similarly, the dimensionless specific surface 
energy of the 1β-sheet face parallel to the β-sheet lengthening axis can be written as 
ψ
h
= n
h
α
h
− n
c
α
c
       (5) 
Note, that in this expression we do not consider the contribution of possible hydrogen 
bonds between side-chains. 
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 To provide insight into the effect of pH on the formation of amyloid fibrils we 
assume that a peptide has only one titratable group (Fig. 1), and that only the side 
chain of this group can be either in a protonated or deprotonated state at pH values 
which are either below or above its nominal pKa value (note that this implies that the 
titratable carboxylate and ammonium group at the N- and C-terminal residues are not 
considered in our model). Furthermore, we assume that the hydrogen and 
hydrophobicity mediated bonding is the same for all amino acids. The dimensionless 
specific surface energies ψ and ψh from Eqs. 4 and 5 can then be calculated by 
considering that each peptide in the fibril can form n =10  hydrogen bonds between 
two nearest neighbour β-strands in a β-sheet, and n
h
=10  hydrophobicity mediated 
bonds between any two nearest neighbour β-strands. As each peptide has only one 
titratable group, the number of columbic bonds n
c
=1 . The values used for the 
interactions energies are ε = 2 kT (a typical hydrogen bonding energy measured 
experimentally 
32
) so that α = ε / 2kT =1 , ε
h
= 0.2 kT (a value for the hydrophobic 
interactions often used in protein simulations 
33
) so that α
h
= ε
h
/ 2kT = 0.1 . While 
these two bond energies are constant, the columbic bond energy between two charged 
amino acids is described by the Debye Hueckel potential, eq. 2, and depends both on 
distance between the amino acids and the solution conditions (i.e. pH, salt 
concentration). Assuming that the peptides within the fibril are arranged parallel, the 
distance between the neighboring amino acids in a β-sheet is 0.48 nm, so that 
α
c
= ε
c
/ 2kT = eV (r = 0.48nm) / 2kT . In all our considerations the titratable group is 
glutamic acid and as more base is added its side chain group loses a proton at its 
characteristic pKa = 4.25 value. Its fractional negative charge f can be calculated from 
eq. 1, the dimensionless potential eV (r) / kT
 
of glutamic acid amino at distance 
r = 0.48  nm can be calculated from eq. 2.  
 
Fibril solubility. As the effect of changing molecular interactions between β-
strands on the fibril solubility, C
e
, is difficult to determine experimentally, we 
estimate it theoretically by making use of the vanÕt Hoff equation and the Haas-
Drenth lattice model
34
 for protein crystals. The integrated vanÕt Hoff equation is given 
by C
e
=C
r
e
−λ  where C
r
 is a practically temperature independent reference 
concentration and λ = L / kT  is the dimensionless latent heat of peptide aggregation 
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into β-sheets. Here L is the latent heat of peptide aggregation into such aggregates. In 
the Haas-Drenth lattice model
34
 for protein crystals λ is half the dimensionless 
binding energy of a peptide in an aggregate, that is λ = 2ψ + 2ψ
h
. The fibril solubility 
is then given by 
C
e
=C
r
e
−2 ψ+ψh( )        (6) 
Both theoretical considerations
31
 and a computer-simulated peptide solubility 
diagram
35-37
 reveal that for the irreversible elongation of differently thick amyloid 
fibrils (i.e. fibrils composed of different number of β-sheet layers), thermodynamics 
requires different ranges of the concentration C1 of monomeric peptides (β-strands) in 
the solution, see Fig. 2. These ranges are limited by the equilibrium concentration (or 
solubility) C
e
 of the bulk fibrillar phase and the increasingly higher equilibrium 
concentrations (or solubilities) C
1β , C2β , C3β , etc. of the fibrils constituted of one β-
sheet of any length, two β-sheets of any length, three β-sheets of any length, etc., 
respectively. Hereafter, a fibril of i β-sheets will be denoted as iβ-sheet. The 
solubilities are merely the C1 values at which the respective iβ-sheets neither lengthen 
nor dissolve, and C
iβ  is related to Ce  by the expression 
31
 ( i =1, 2, 3, É)!
C
iβ =Cee
2ψh /i         (7)!
The C
1
>C
1β  range corresponds to metanucleation, a process of fibril formation 
without energy barrier, because then each protein monomer (i.e. single β-strand) in 
the solution acts as fibril nucleus as attachment of another monomer to it allows 
irreversible elongation.  
When C
1
>C
2β , 2β-sheets can lengthen irreversibly. Importantly, in the 
C
2β <C1 <C1β  range the 1β-sheets tend to dissolve and their appearance is due to 
fluctuations. In this range the fibril nucleus is a 1β-sheet plus one β-strand attached to 
the 1β-sheet side so that a fibril prenucleus is any of the randomly formed, differently 
long 1β-sheets in the solution. The situation is analogous with the 3β-sheets, the 
general rule is that in the ranges 
31
 ( i = 0 , 1, 2, 3É) 
C
e
e
2ψh /(i+1) <C
1
<C
e
e
2ψh /i       (8) 
all differently long iβ-sheets are fibril prenuclei, and these sheets plus one β-strand 
attached to one of their two sides are the nuclei of the ( i+1)β-sheet-thick fibrils that 
can lengthen irreversibly. 
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Nucleation rate. Which fibrils form in a protein solution, and how fast, is 
determined by the nucleation rate J (m
-3
 s
-1
). Experiments on protein aggregation are 
often performed at fixed temperature T, and based on the phase diagram discussed 
above we can write down expressions for J in the nucleation and metanucleation 
ranges. The concentration C1 dependence of the nucleation rate in the metanucleation 
range (range i = 0 ) in which each monomer in the solution acts as a fibril nucleus is 
given by 
27
 (C
1
>C
1β ) 
J = A
1
C
1
2
1− A
2
C
1
−1( )        (9) 
where A
1
= 2k
e
/C
e
,  A
2
=C
e
e
2ψh , ke is the attachment frequency of monomers to one 
of the two hydrogen-bond sides of a given monomer at equilibrium, Ce is the fibril 
solubility, and the threshold concentration C
1β  is obtained from eq. 7 with i =1 and is 
given by 
C
1β =Cee
2ψh         (10)  
The formula for J in the ith nucleation range is given by 
27
 ( i =1, 2, 3, É) 
J = A
1
C
1
i+2 1− A2C1
−1
1− A
3
C
1
i( )
2        (11) 
with A
1
= 4k
e
/C
e
i+1( )e−2ψi,  A2 =Cee2ψh /(i+1) and A3 =Ce−ie2ψh  in the supersaturation 
ranges given in eq (8). 
 
RESULTS 
Our model peptide (Fig. 1) is composed of 10 amino acids only one of which has a 
titratable group (glutamic acid). Changing the solution conditions (pH, salt 
concentration, and solvent) will affect the interactions between the glutamic acids in 
neighbouring β-strands within the fibril and in turn the fibril nucleation rate. The 
application of our theoretical framework to calculate the concentration dependence of 
the nucleation rate follows a three-step recipe: Step 1 is to calculate the dimensionless 
specific surface energies ψ  and ψh from eqs. 4 and 5. This requires knowledge of the 
conformation of the peptide within the fibril as they determine the number, n, of 
bonds between the amino acids, and the associated binding energies; Step 2 is the 
calculation of the fibril solubility C
e
 from eq. 6, which requires knowledge of the 
! 9 
solubility C
r
 of a fibril that serves as a reference. Step 3 is the calculation of the 
nucleation rate J from eqs. 9 and 11 which requires knowledge of the elongation rate, 
ke. 
 
Effect of solution pH 
As mentioned in the introduction, solution pH can strongly affect the fibrillation rate. 
In our model peptide, with increasing pH the side chain group of the glutamic acid 
loses a proton at its characteristic pKa = 4.25 value and becomes increasingly 
negatively charged. Its fractional negative charge f can be calculated from eq. 1 (see 
Fig. 3) and the distance dependence of the Debye Hueckel potential (eq. 2) describing 
the repulsive interaction between glutamic acid in water at pH = 3, 4.5 and 7 is shown 
in Fig. 4(a). The values used to obtain this figure are λ
B
= 0.7  nm (calculated for 
water with a dielectric constant ε
r
= 80  at T = 300 K) and λ
D
=1  nm for 100 mol/m
3
 
(100 mM) salt in water. The corresponding pH dependence of the dimensionless 
specific surface energies per amino acid, α
c
, as defined above is illustrated in Fig.  
4(b). As can be seen from the figure, with increasing pH the value of α
c
 increases and 
the interaction energy becomes increasingly repulsive. The values of α
c
 obtained at 
pH = 3, 4.5, and 7 are 0.04, 0.44, and 0.69, respectively. Step 1 of the recipe is to 
calculate the dimensionless specific surface energies from eqs. 4 and 5 which yields 
ψ = 11, 10.7, and 10.5 and ψh = 1, 0.7, and 0.5 at pH = 3, 4.5 and 7, respectively (see 
Fibril model for the n values used). Step 2 of the recipe is to calculate the fibril 
solubility C
e
 and its pH dependence. This can easily be done by assuming that 
C
e
= 6.0!10
21  m
-3
 (= 10 µM) for a completely uncharged peptide (see, e.g., Ref. 38). 
Then eqs. 4 and 5 can be used to calculate ψ =11 and ψ
h
=1  (for the uncharged 
peptide), and to obtain C
r
=1.6!10
32  m
-3
 from eq. 6. Assuming that the reference 
concentration is independent of pH, and using it together with the values for 
ψ  and ψh (for the charged peptide) in eq. 6, yields Ce = 6.6!10
21  m
-3
 (= 11 µM), 
1.9!10
22 m
-3
 (= 32 µM), and 3.7!1022  m-3 (= 61 µM) at pH = 3, 4.5, and 7, 
respectively. Fig. 5a illustrates that C
e
 increases with pH, implying that with 
increasing pH (i.e. charge) the fibril becomes more soluble. Using a typical value for 
the elongation rate, k
e
=10
4  s
-1
 (see, e.g. Knowles et al. 
39
), and assuming that it is 
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independent of pH, allows us to calculate the J(C1) dependence from eqs. 9 and 11 
(step 3 of the recipe). As can be seen from Fig. 5b, the characteristic feature of the 
J(C1) dependence is a sharp rise at the transition concentrations, Ciβ , over a narrow 
concentration range. For example the rise at the nucleation/metanucleation border C
1β  
is more than 5 orders of magnitude, which is of particular relevance as for C
1
<C
1β  
fibril nucleation becomes biologically irrelevant because only one fibril can be 
nucleated within a day in a volume of ~1µm3 comparable to the volume of a cell. 
Importantly, the main effect of increasing the pH is to shift C
1β  to higher 
concentrations and to hamper protein fibrillation because metanucleation commences 
at higher concentrations (see Fig. 5b). Using the C
e
 values from above, the threshold 
concentrations at pH = 3, 4.5 and 7 are C
1β = 4.8!10
22  m
-3
 (= 80 µM), 
C
1β = 7.9!10
22 m
-3
 (= 132 µM), and C
1β =1.1!10
23m
-3
 (= 181 µM), respectively (Fig. 
5a).  
Our finding that increasing the overall charge of the peptide hampers protein 
fibrillation is in agreement with the experimental work by Carrick et al. 
19
 in which 
they used the important role of charge to design peptides for which pH can be used as 
a reversible switch for the formation of hydrogels. One of the peptides they 
considered (P11-4) is composed of 11 amino acids including Arginine at position 3 
and glutamic acid at positions 5, 7, and 9. It has a net charge of +1 from the Arginine 
at pH < 3, but with increasing pH the Glutamic acids become increasingly protonated 
so that the net charge of the peptide is -2 at pH > 8. For this peptide the fibrillar gel is 
stable at low pH (corresponding to a low net charge) and becomes unstable at higher 
pH (corresponding to a higher net charge), see Fig. 1a of Ref. (21). Our findings also 
agrees with the work by Sammas et al. 
40
 on insulin where they show that insulin 
fibrils disaggregate with increasing charge on the protein. It also agrees with the 
observation that the concentration above which monomeric peptides (of sequence 
FEFEFKFK) aggregate correlates with their overall charge 
16
. 
We emphasise, that in these considerations we have assumed that the pKa 
value of glutamic acid is not affected by the solution pH. When discussing the effect 
of solvent below, it will become clear that changes in pKa values can have drastic 
effects on the fibril nucleation rate. Consequences of changes in pKa with pH will be 
revisited in the DISCUSSION. 
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Effect of salt concentration 
Adding salt to a solvent shields the electrostatic interaction between charged species 
in the solution. The main effect of changing the salt concentration on the columbic 
interaction between the glutamic amino acids is to change the Debye screening length 
λ
D
, while we assume that the Bjerrum length λ
B  and the pKa value are not affected. 
Reducing the salt concentration from 100 mol/m
3
 (100 mM) to 1 mol/m
3
 (1 mM) salts 
in water increases λ
D
 from 1 nm to 10 nm. The effect of this increase on the distance 
dependence of the Debye Hueckel potential from eq. 2 describing glutamic acid in 
water and the dimensional specific surface energy per amino acid αc are shown in Fig. 
4 by the dashed lines. Decreasing the salt concentration increases the repulsion 
between two charged amino acids, and this effect becomes stronger with increasing 
pH. The values of α
c
 obtained at pH = 3, 4.5, and 7 are 0.02, 0.29, and 0.45, 
respectively. In order to calculate the effect of salt concentration on the J(C1) 
dependence we calculate ψ  and ψh (step 1 of recipe). From Eqs 4 and 5 we obtain 
that ψ = 11.0, 10.6, and 10.3 and ψh = 1.0, 0.6, and 0.3 each at pH = 3, 4.5, and 7, 
respectively. Step 2 of the recipe is to calculate the pH dependence of the solubility. 
Assuming that C
r
=1.6!10
32  m
-3
 is again independent of pH and salt concentration, 
and with the ψ  and ψh  values above, we obtain from eq. 6 that Ce = 7.2!10
21  m
-3
 (= 
12 µM), 3.6!1022m-3 (= 59 µM), and 9.6!1022  m-3 (= 160 µM), at pH = 3, 4.5, and 
7, respectively. As can be seen from Fig. 5a, the increase with pH in the value of C
e
 
is more pronounced when less salt is present. As in the previous example, the J(C1) 
dependence at different pH values is obtained from eqs. 9 and 11 with k
e
=10
4  s
-1
. 
Fig. 5b shows that the shift of C
1β  to higher concentrations is even more pronounced 
when less salt is present, which hampers protein fibrillation even more. Using the C
e
 
values from above, the threshold concentrations obtained from eq. 10 at pH = 3, 4.5 
and 7 are C
1β = 4.8!10
22  m
-3
 (= 80 µM), 1.1!1023m-3 (= 179 µM), and 1.8!1023  m-3 
(= 296 µM), at pH = 3, 4.5, and 7, respectively. Our finding that adding salt decreases 
the fibril solubility and increases the nucleation rate is consistent with the 
experimental observation by Carrick et al. 
19
 that the transition range in which fibrillar 
gels form and are stable is shifted to higher pH values (at which the peptide has a 
! 12 
higher charge to compensate for the higher salt concentration and screening between 
the charged residues). Also, in the work by Hoyer et al. 
10
 on α-synuclein they found 
that with increasing pH aggregation lag time increases. 
 
Effect of solvent 
The main effect of changing the solvent from e.g. water to a less polar solvent 
is that the dielectric constant ε
r
 decreases. This affects the electrostatic interaction 
between two charged amino acids, as in the expression from Debye Hueckel theory 
eq. 2 the Bjerrum length increases and the Debye length decreases with decreasing  
(see Fig. 6a). The combined effect on the Debye-Hueckel potential calculated at pH = 
4.5 is that the electrostatic screening is more effective in polar solvents like water 
compared to non-polar ones (Fig. 7a). The corresponding decrease of the 
dimensionless specific surface energies per amino acid due to columbic bonding, α
c
, 
is shown in Fig. 7b. In order to calculate the effect of solvent on the J(C1) dependence 
we first calculate the ψ  and ψh (step 1 of recipe) at different values for the dielectric 
constant. For ε
r
= 80 , 50 and 20 and 100mM salt concentration, the values for the 
Debye length are λ
D
=1.0  nm, 0.8 nm, 0.5 nm and for the Bjeruum length are 
λ
B
= 0.7  nm, 1.1 nm, 2.8 nm, respectively. The corresponding values of α
c
 obtained 
for ε
r
= 80 , 50 and 20 are 0.28, 0.40, and 0.69, respectively. Using these values in eqs 
4 and 5 we obtain that ψ = 10.7, 10.6, and 10.3 and ψh = 0.7, 0.6, and 0.3 each at 
ε
r
= 80 , 50, and 20, respectively. Step 2 of the recipe is to calculate the pH 
dependence of the solubility. Assuming that C
r
=1.6!10
32  m
-3
 is independent of the 
solvent, and with the ψ  and ψh  values above, we obtain that Ce = 2!10
22  m
-3
 (= 31 
µM), 3!1022  m-3 (= 49 µM), and 10!1022m-3 (= 160 µM), at ε
r
= 80 , 50, and 20, 
respectively. As can be seen from Fig. 8a, increasing the dielectric constant decreases 
C
e
 and the fibrils are less soluble. As in the previous example, we calculate the J(C1) 
dependence at different pH values from eqs. 9 and 11 with k
e
=10
4  s
-1
. Fig. 8b shows 
that the main effect of increasing ε
r
 is to shift the threshold concentration C
1β  to 
lower concentrations and to promote protein fibrillation. Using the C
e
 values from 
above, the threshold concentrations for ε
r
= 80 , 50 and 20 are C
1β = 8!10
22  m
-3
 (= 
ε
r
! 13 
130 µM), 10!1022 m-3 (= 164 µM), and 17!1022  m-3 (= 296 µM), respectively. 
Interestingly, the prediction that increasing dielectric constant decreases fibril 
solubility and promotes fibrillation is in contrast to experimental observations (see 
e.g. Ref. 
41
).  
In order to resolve this discrepancy, it is necessary to consider the fact that the 
pKa value of the charged residue also depends on the solvent (see Methods). To 
estimate this effect we are considering glutamic acid in water (with ε
r
= 80  and 
pK
a
= 4.25 ) as a reference solute solvent at T = 300 K, and using eq. 3 with (a+ + a-) 
= 0.35 nm as a diameter for the OH group, predicts that the pKa values decrease with 
increasing dielectric constant (see Fig. 6b), for example pK
a
= 5.54 , 4.51 and 4.25 at 
ε
r
= 20 , 50, and 80, respectively.  
The higher pKa values in less polar solvents leads to a cascade of effects, it 
decreases the fraction of the ionised side-chain group of glutamic acid, which leads to 
a decrease in the electrostatic repulsion between charged amino acids, which leads to 
a decrease in the dimensionless specific surface energy per amino acid due to 
columbic bonds and the corresponding values for the dimensionless specific surface 
energies, which in turn lowers the fibril solubility and the threshold concentration and 
hence promotes protein fibrillation.  
In the considerations above we found that at pH = 4.5 and salt concentration 
100 mM the solubility of fibrils in water with ε
r
= 80  is Ce = 2!10
22  m
-3
 (= 31 µM),
 
and that replacing water with a solvent with ε
r
= 20  leads to a solubility of 
C
e
=10!10
22  m
-3
 (= 160 µM), see also Fig. 8a. However, considering that the pKa 
value of glutamic acid increases to 5.54 (from 4.25 in water) leads to a decreased 
electrostatic repulsion and  decreases to 0.09 (from 0.69 in water), see Fig. 7 
dashed lines. In these calculations we have used λ
D
= 0.5  nm and λ
B
= 2.8  nm from 
above, as they are independent of the pKa value. Using the so obtained values in eqs 4 
and 5 yields the corresponding values for dimensionless specific surface energies 
ψ = 10.9 and ψh = 0.9. Assuming again that  m
-3
 is independent of the 
pKa value, the solubility is C
e
= 9!10
21  m
-3
 (= 14 µM), which is much lower than the 
solubility in water (Fig. 8a). As before, the J(C1) dependence with ke =10
4  s
-1
 is 
obtained from eqs. 9 and 11, and Fig. 8b shows that with a higher value of pKa, the 
α
c
C
r
=1.6!10
32
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threshold concentration C
1β  is shifted to lower concentrations and protein fibrillation 
is much enhanced. Using the C
e
 values from above, the threshold concentration is 
C
1β = 5!10
22  m
-3
 (= 88 µM). 
The main result from these considerations is that an increase of the pKa value 
opposes the effect of the reduced dielectric constant, and this effect can dominate so 
that the fibril nucleation rate can be enhanced in less polar solvents (see Fig.8b) in 
line with experimental observations (see e.g. Ref. 
41
). This effect is more pronounced 
for solution conditions at which the fractional charge of the residue is large, i.e in this 
example at higher pH values. In the limiting case where the shift of the pKa value 
increases such that the fractional charge of the residue approaches zero, the nucleation 
rate will be identical to that of an uncharged system, i.e. close to that of the nucleation 
rate shown in Fig. 5b at pH = 3.   
 
DISCUSSION 
 Main results. The main results from this study are that (i) increases in 
solution pH that increase the net charge of the peptide make fibrils more soluble and 
hamper protein fibrillation; (ii) increasing the salt concentration decreases the 
solubility of fibrils and promotes protein fibrillation; (iii) changing the solvent from 
water to a more polar one increases the solubility of the fibrils and hampers protein 
fibrillation. Importantly, when considering the effect of an increased pKa value of 
glutamic acid in polar solvents will lower the fibrils solubility and promote protein 
fibrillation. The latter of these two opposing effects can dominate, so that fibril 
nucleation can be enhanced in less polar solvents. 
  
 Importance of fibril solubility and threshold concentration. As in our 
previous work 
29
, the results obtained highlight the important role of the fibril 
solubility C
e
 and the threshold C
1β  concentration in amyloid fibril nucleation. 
Substitution of eqs. 4 and 5 into eq. 6  
C
e
=C
r
e
−2(ψ+ψh ) =C
r
e
−(nε+2nhεh−2ncεc )/kT     (12) 
allows us to express the solubility in terms of the binding energy between neighboring 
β-strands in the fibril, and substitution of eqs. 4 and 5 into Eq. 10 yields the 
corresponding expression for the threshold concentration 
! 15 
C
1β =Cee
2ψh =C
r
e
−(nε+nhεh−ncεc )/kT .       (13) 
These two simple analytical expressions, in combination with the Debye Hueckel 
theory eq. 2, allow us to rationalize the results obtained.  
 Increases in solution pH, that increase the net charge and thereby ε
c
, increase 
C
e
 (as can be seen from eq. 12) and fibrils become more soluble. The increase in ε
c
 
also increases C
1β  (as can be seen from eq. 13) which hampers proteins fibrillation 
because metanucleation commences at higher concentrations. Increasing the salt 
concentration lowers ε
c
 which decreases C
e
 (as can be seen from eq. 12) and fibrils 
become less soluble. The decrease in ε
c
 also decreases C
1β  (which can be seen from 
eq. 13) which promotes proteins fibrillation because metanucleation commences at 
lower concentrations. Changing water to a more polar solvent decreases the dielectric 
constant ε
r
 which in turn increases ε
c
 and increases C
e
 (see eq. 12) and fibrils 
become more soluble. Increasing ε
c
 increases C
1β  (see eq. 13) which hampers 
proteins fibrillation. Considering that the pKa value increase in non polar solvent 
opposes this effect as  decreases, and eqs. 12 and 13 show that in turn  and  
decrease and protein fibrillation is promoted.   
The general rule that emerges from these considerations is that changes in the 
solution conditions that increase the bonding energy of peptides in the fibril decrease 
the fibril solubility and promote amyloid fibril nucleation. The general rule is in 
accord with our recent results 
29
 on amyloid polymorphism where changes in the 
conformation of the fibril building blocks or their packing that increase their binding 
energy decrease fibril solubility and promote protein fibrillation. The results presented 
in this study further illustrates the power of our theoretical framework which provides 
a tool to qualitatively and quantitatively predict effects of amino acid sequence, 
polymorphism and solvent based on the fundamental interactions between the fibril 
building blocks. 
 
Experimental verification. A verification of our results of the effect on 
solution conditions on amyloid fibril nucleation requires a direct measurement of the 
fibril nucleation rate. At present, the numerous experimental studies are mainly for 
the lag time and maximal rate of overall aggregation. Time-resolved optical 
experiments that measure the fluorescence signal arising from dye molecules such as 
ε
c
C
e C1β
! 16 
thioflavin T bound to the protein aggregates enable determination of lag time and the 
maximal rate of overall aggregation. This type of experiments does not allow a 
reliable determination of J, as it is well know that it depends on other factors such as 
solution agitation, detection limit, because post-nucleation processes such as 
fragmentation can affect the overall aggregation process.  
It is worth noting that some generalized rate equations
42,43
 commonly used to 
analyze time-resolved optical experiments describing the fibrillation kinetics contain a 
semiempirical quantity called the fibril nucleation rate introduced ad hoc, which does 
not correspond to the nucleation rate as obtained in classical nucleation theory
44
. A 
precise method of experimentally obtaining an estimate of the nucleation rate is to 
measure the probability to form at least one fibril of a given size as a function of 
time
45
. 
 
Effect of pH on pKa value. A very important point in our discussions of the 
effect of pH and salt on the fibril nucleation rate is that we assumed that the pKa 
value does not depend on pH. With increasing pH the fraction of ionized glutamic 
acids in solution increases and the remaining ones should bind their protons more 
strongly due to the increased electro-negative environment, resulting in a rise in their 
pKa value. This effect has been seen in other protein systems, like the tetrameric M2 
proton channel
46
 where instead of seeing cooperative deprotonation of all 4 histidine 
side chains at pH 6 (the pKa value of isolated histidine), the pKa values range from 5 
to above 8. In absence of an analytical theory describing the effect of pH on the pKa 
value on glutamic acid, we can only qualitatively predict that an increase of the pKa 
value with pH opposes the effect of pH on the nucleation rate discussed above (Fig. 5) 
and will promote protein fibrillation, similar to the effect of solvent on the pKa value 
discussed above (Fig. 8b). In the limiting case when the pKa value increase such that 
the fractional charge of the residue approaches zero, the nucleation rate becomes that 
of an uncharged system (i.e close to the rate shown in Fig. 5b at pH = 3). 
 
CONCLUSIONS 
We conclude that the combination of our newly developed nonstandard nucleation 
theory with Debye Hueckel theory to describe the interactions between the fibril 
building blocks can be used to predict the concentration dependence of the nucleation 
rate at different pH, salt concentration and solvent. The general rule that emerges 
! 17 
from these considerations is that changes in the solution conditions that increase the 
bonding energy of peptides in the fibril decrease the fibril solubility and promote 
amyloid fibril nucleation. Our results highlight the important role of the fibril 
solubility C
e
 and the threshold C
1β  concentration in amyloid fibril nucleation and eq. 
12 and 13 allow us to rationalise the results obtained. The analytical relations between 
the nucleation rate, the fibrils solubility and the binding energies between the fibril 
building blocks might prove a valuable tool how to control amyloid fibril formation 
by changing the solution conditions.  
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FIGURES 
 
 
 
 
Fig. 1. Illustration of an amyloid fibril (2β-sheet) composed of two β-sheets one of 
which is constituted of 9 peptides (bottom β-sheet) and the other of 4 peptides (top β-
sheet). In the fibril model each peptide is in an extended β-strand conformation and 
composed of 10 amino acids (cubes), only one of which is a titratable group (shown 
in red). The peptides within the fibril are arranged parallel to each other and each 
amino acid can form bonds (visualised by the red and blue lines) with nearest 
neighbour amino acids only. See Method for a detailed description of the model. 
  
! 19 
 
Fig. 2. Monomer concentration ranges determined by the fibril solubility C
e
, the 
metanucleation border C
1β , and intermediate concentrations Ciβ for  i ≥ 2 . 
 
 
  
 
  
! 20 
 
 
Fig. 3. pH dependence of the fraction f of the (negatively charged) ionised side-chain 
group of glutamic acid obtained from eq. 1 with pKa = 4.25. 
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Fig. 4. (a) Distance dependence of Debye Hueckel potential from eq. 2 describing 
glutamic acid in water with pKa = 4.25 at pH = 3, 4.5 and 7 as indicated. The vertical 
dashed black line is at a hydrogen bonding distance r = 4.8 nm. The Bjerrum length 
used in this plot is λB = 0.7nm, and the Debye lengths used are λD = 10 nm (dashed 
line, 1 mol/m
3
) and 1 nm (solid lines, 100 mol/m
3
), respectively. (b) Corresponding 
pH dependence of the dimensionless specific surface energies per amino acid, α
c
, due 
to columbic bonds. The dashed and solid lines are obtained for salt concentrations 1 
mol/m
3
 and 100 mol/m
3
, respectively. 
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Fig. 5. (a) Dependence of the fibril solubility C
e
  and threshold concentration C
1β  
on 
pH in water and pKa = 4.25. (b) Concentration dependence of the nucleation rate at 
pH = 3, 4.5 and 7 as indicated. As in Figure 4, the value for the Bjerrum length used 
is λB = 0.7 nm and the Debye lengths are λD = 1 nm (dashed lines, 1 mol/m
3
) and 10 
nm (solid lines, 100 mol/m
3
), respectively. 
  
0 50 100 150 200 250 300
C
1
 (!M)
1
10
5
10
10
10
15
10
20
10
25
J 
(m
-3
s-
1
)
2 3 4 5 6 7
pH
0
50
100
150
200
250
300
C
e,
 C
1
` 
(!
M
)
4.53 7
C
e
C
1`
(a)
(b)
! 23 
 
Fig. 6. (a) Dependence of the Debye length λD (red line) and Bjerrum length λB (black 
line) on dielectric constant obtained at T = 300K and salt concentration 100mM. (b) 
Dependence of the pKa value of glutamic acid on the dielectric constant εr , obtained 
from eq.3. 
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Fig. 7. (a) Distance dependence of Debye Hueckel potential at ε
r
= 80 , 50 and 20 as 
indicated at pH = 4.5. The solid lines have been calculated for pKa = 4.25 and the 
dashed line has been calculated for pKa = 5.54. The vertical dashed black line is at a 
hydrogen bonding distance r = 0.48 nm. (b) The dimensionless specific surface 
energies per amino acid α
c
 (which is equal to half the value of the Debye Hueckel 
potential at hydrogen bonding distance r = 0.48 nm) as a function of ε
r
. The solid and 
dashed lines have been calculated for pKa = 4.25 and 5.54, respectively. 
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Fig. 8. (a) Dependence of the fibril solubility (black lines) and the threshold 
concentration (red lines) on the dielectric constant ε
r
 at pH = 4.5. The solid and 
dashed lines correspond to pKa values of 4.25 and 5.54, respectively. (b) 
Concentration dependence of the nucleation rate at ε
r
= 80  (red), 50 (black) and 20  
(blue) at pH = 4.5. The solid and dashed lines correspond to pKa values of 4.25 and 
5.54, respectively. 
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